Finch Cybernetics is a premium medical and augmentation company. It fits people with prostheses, implants, and neural interfaces, then provides the surgery, rehabilitation, and continuing maintenance needed to use them as parts of a living body. Its systems can restore movement, sensation, communication, and control over one’s own body. Keeping those abilities, however, depends on access to clinics, compatible parts, firmware, records, and professional recognition controlled by Finch.
The company grew from the neuroprosthetic tradition associated with Mireille Finch. She argued that an integrated device should let a patient move and feel with dignity, rather than turn their body into a mounting point for machinery. Finch built its reputation on careful fitting and long support. The ease with which someone could inhabit an augmented body became both a standard of care and a visible sign of what they could afford.
Living with Finch
Within Finch systems, Grace determines maintenance coverage. It is not a general currency. Coverage governs how quickly a clinic responds, which replacement parts a patient can obtain, and their access to firmware refinement, sensory calibration, and emergency support.
With high Grace, a repair can feel as routine and dependable as an ordinary civic service. Patients with less coverage wait longer, live with defects the clinic considers tolerable, accept substitute parts, and face stricter judgments about whether lost function warrants urgent care.
A transit mechanic’s Finch hand develops a slight tactile delay after a firmware update. It still closes safely, so the clinic treats the problem as non-emergency. She can work, but she cannot trust the fraction of a second between touching a hot coupling and feeling it. Her supervisor removes her from certified repair tasks while she waits for an appointment. The defect is too small to earn priority care and large enough to cut her pay. Her household rearranges shifts and travel around a problem almost invisible to anyone who does not live inside it.
Wealth changes how long a person must live with that uncertainty. It buys faster care, better-matched parts, private recovery, and discretion when a body falls out of calibration. Clinicians and technicians are also tied to the system: years spent learning Finch’s proprietary standards make independent practice difficult, even for staff who object to the triage rules they must enforce.
What Finch Controls
Finch supplies premium prostheses and implants, high-bandwidth interfaces, rehabilitation, sensory and motor calibration, and long-term service. Much of its power comes from deciding how those systems are maintained. A device may require proprietary diagnostics, matched components, specialist surgery, and firmware whose safety certification remains tied to Finch rather than moving with the patient to another provider.
Its brain-computer interfaces give a living mind access to other systems; they do not create a separate person. Finch implants and maintains these interfaces. It also builds embodiment bridges that let uploads or hybrid minds inhabit systems through which they can sense and act.
Those bridges have a limited role. Finch does not copy or host uploads; providers such as EternaMind do that. Finch controls the upload’s access to sensation and movement through the bridge. It does not settle the questions of personal continuity or custody described in Mind Uploading.
Finch also depends on independent suppliers. Cryonix provides thermal materials and the capacity to operate demanding implants, clinics, and continuity systems within reliable thermal limits. Finch integrates and services bodies. Buying materials from Cryonix gives it no authority over the wider materials industry or the upload market.
Clinics and Territory
Finch’s facilities are concentrated on Luna and across the Earth-Moon service network. Clinic habitats and surgical facilities sit near major transit routes.
Its premium operations once included much of the far-side lunar materials economy. The Cinderlace Licensing War broke up that arrangement. Cryonix gained sovereign leverage over thermal works and materials districts, while Finch retained a narrower domain of clinical care and embodiment services.
The division matters to patients because one body can depend on both companies. Finch provides the integration and maintenance; Cryonix supplies the materials and certified thermal operating limits within which the hardware remains reliable.
Bodily Freedom and the Cost of Leaving
Finch often aligns with Enhancement Liberals. Reliable augmentation can give someone greater freedom to move, perceive, communicate, or choose their form. Those are substantial gains in bodily autonomy.
The difficulty comes when a patient wants to leave. Changing providers can mean further surgery, lost records, incompatible components, or time without an essential function. A person may have more control over what their body can do while having little practical choice about who maintains it.
The Tycho Exclusion Riots made the unequal terms of that care public. During a firmware cascade, lower-coverage patients were denied protections reserved for premium clients. Service technicians leaked triage evidence showing how access to dignified integration depended on a patient’s contract. Finch survived the crisis by making coverage and liability clearer; it did not make maintenance equal.
During the Neural Network Defense Campaign, Finch protected clinics, service vaults, and embodiment bridges against seizure and fragmentation. Patients needed that network to remain intact. Keeping it secure also strengthened their dependence on Finch-administered care: the infrastructure preserving their bodily function was the infrastructure through which the company kept control.
Finch’s promise is to make technology work as part of a person’s body, with the fitting and support that requires. For patients, the continuing question is who decides when that support arrives, and what they must live without while they wait.